Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease course.

Autor: Chanson N; AP-HP, Université Paris Saclay, department of internal medicine and clinical immunology, Bicêtre Hospital, Le Kremlin Bicêtre, France., Galvagni A; AP-HP, Université Paris Saclay, department of internal medicine and clinical immunology, Bicêtre Hospital, Le Kremlin Bicêtre, France., Ramos-Casals M; Department of Autoimmune Diseases, ICMiD, Hospital Clinic, Barcelona, Spain.; Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain., Ruiz JI; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pm Suijkerbuijk K; Department of Medical Oncology, UMC Utrecht Cancer Center, Utrecht University, Utrecht, the Netherlands., Benesova K; Department of Internal Medicine and Rheumatology, Universitätsklinikum Heidelberg, Germany., Kerschen P; Service de Neurologie, Centre Hospitalier de Luxembourg, Luxembourg-Ville, Luxembourg., Karam JD; Internal Medicine and RECIF, CHU Amiens Picardie, Amiens, France., Belkhir R; AP-HP, Université Paris Saclay, department of rheumatology, Bicêtre Hospital, Le Kremlin Bicêtre, France., Outh R; Service de Médecine interne et générale, Centre Hospitalier de Perpignan, Perpignan, France., Closs-Prophette F; Médecine Polyvalente, Centre Hospitalier du Mans, France., Morillo JSG; Department of Internal Medicine, Universitario Hospital Virgen Del Rocio, Sevilla, Spain., Robles-Marhuenda Á; Internal Medicine Department, Hospital universitario La Paz, Madrid, Spain., Michot JM; Departement D'Innovation Therapeutique et D'Essais Precoces, Institut Gustave Roussy, Universite Paris-Saclay, Villejuif, F-94805, France., Voisin AL; Departement D'Innovation Therapeutique et D'Essais Precoces, Institut Gustave Roussy, Universite Paris-Saclay, Villejuif, F-94805, France., Messayke S; Departement D'Innovation Therapeutique et D'Essais Precoces, Institut Gustave Roussy, Universite Paris-Saclay, Villejuif, F-94805, France., Laparra A; DIOPP, Institut Gustave Roussy, Universite Paris-Saclay, Villejuif, F-94805, France., Robert C; Department of Dermatology, Institut Gustave Roussy, University Paris-Saclay, Villejuif, F-94805, France., Suarez-Almazor M; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mariette X; AP-HP, Université Paris Saclay, department of rheumatology, Bicêtre Hospital, Le Kremlin Bicêtre, France.; University Paris-Saclay; INSERM; CEA, Centre Immunology of Viral Infections and Autoimmune Diseases, IDMIT, UMR1184, Department IBFJ, Le Kremlin-Bicêtre, France., Lambotte O; AP-HP, Université Paris Saclay, department of internal medicine and clinical immunology, Bicêtre Hospital, Le Kremlin Bicêtre, France.; University Paris-Saclay; INSERM; CEA, Centre Immunology of Viral Infections and Autoimmune Diseases, IDMIT, UMR1184, Department IBFJ, Le Kremlin-Bicêtre, France.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Dec 23. Date of Electronic Publication: 2024 Dec 23.

Development and preliminary psychometric testing of a new OA pain measure – an OARSI/OMERACT initiative

Autor: Hawker, G.A. ^{†, ‡, §}, Davis, A.M. ^{‡, ║, ¶}, French, M.R. ^§, Cibere, J. ^{#, ††}, Jordan, J.M. ^‡‡, March, L. ^§§, Suarez-Almazor, M. ^║║, Katz, J.N. ^¶¶, Dieppe, P. ^##

Publikováno v: In Osteoarthritis and Cartilage 2008 16(4):409-414

Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group.

Autor: Ghosh N; Department of Medicine, Division of Rheumatology, Hospital for Special Surgery/Weill Cornell Medical College, 535 E 70th St, New York, NY, USA. Electronic address: ghoshn@hss.edu., Couette N; Department of Internal Medicine. Division of Rheumatology & Immunology, The Ohio State University, Columbus, OH, USA., van Binsbergen WH; Amsterdam Rheumatology and Immunology Center, Department of Rheumatology & Clinical Immunology, Amsterdam University Medical Center location DBL Amsterdam, the Netherlands., Weinmann SC; Department of Rheumatology & Immunology, Duke University, Durham, NC, USA., Jivanelli B; Hospital for Special Surgery, Kim Barrett Memorial Library, HSS Education Institute, New York, NY, USA., Shea B; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada., Bass AR; Department of Medicine, Division of Rheumatology, Hospital for Special Surgery/Weill Cornell Medical College, 535 E 70th St, New York, NY, USA., Benesova K; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany., Bingham CO; Division of Rheumatology, Johns Hopkins University, Baltimore MD, USA., Calabrese C; Department of Rheumatologic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, USA., Cappelli LC; Division of Rheumatology, Johns Hopkins University, Baltimore MD, USA., Chan KK; Department of Medicine, Division of Rheumatology, Hospital for Special Surgery/Weill Cornell Medical College, 535 E 70th St, New York, NY, USA., Choy E; CREATE Centre, Section of Rheumatology, Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom., Daoussis D; Department of Rheumatology, University of Patras Medical School, Patras University Hospital, Patras, Greece., Goodman S; Department of Medicine, Division of Rheumatology, Hospital for Special Surgery/Weill Cornell Medical College, 535 E 70th St, New York, NY, USA., Hudson M; Jewish General Hospital, Lady Davis Institute for medical research and McGill University, Montreal, Quebec, Canada., Jamal S; Vancouver Coastal Health, University of British Columbia, Vancouver, BC, Canada., Leipe J; Division of Rheumatology, Department of Medicine V, University Hospital Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Germany., Lopez-Olivo MA; The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Suarez-Almazor M; Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA., van der Laken CJ; Amsterdam Rheumatology and Immunology Center, Department of Rheumatology & Clinical Immunology, Amsterdam University Medical Center location DBL Amsterdam, the Netherlands., Meara AS; Department of Internal Medicine. Division of Rheumatology & Immunology, The Ohio State University, Columbus, OH, USA., Liew D; Department of Rheumatology, Austin Health, Department of Clinical Pharmacology and Therapeutics, Austin Health, Australia, Department of Medicine, University of Melbourne, Parkville VIC, Australia., Kostine M; Bordeaux University Hospital, Department of Rheumatology, France.

Publikováno v: Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2023 Feb; Vol. 58, pp. 152110. Date of Electronic Publication: 2022 Oct 26.

OUTCOME MEASUREMENT INSTRUMENTS FOR SAFETY IN RHEUMATOLOGY: A SCOPING REVIEW OF AVAILABLE INSTRUMENTS TO INFORM THE OMERACT SAFETY WORKING GROUP

Autor: Klokker, L., Woodworth, T., Furst, D. E., Tugwell, P., Devoe, D., Williamson, P., Terwee, C. B., Suarez-Almazor, M. E., Strand, V., Leong, A. L., Goel, N., Boers, M., Brooks, P. M., Simon, L. S., Christensen, R.

Publikováno v: Klokker, L, Woodworth, T, Furst, D E, Tugwell, P, Devoe, D, Williamson, P, Terwee, C B, Suarez-Almazor, M E, Strand, V, Leong, A L, Goel, N, Boers, M, Brooks, P M, Simon, L S & Christensen, R 2017, ' OUTCOME MEASUREMENT INSTRUMENTS FOR SAFETY IN RHEUMATOLOGY: A SCOPING REVIEW OF AVAILABLE INSTRUMENTS TO INFORM THE OMERACT SAFETY WORKING GROUP ', Annals of the Rheumatic Diseases, vol. 76, pp. 463-463 . https://doi.org/10.1136/annrheumdis-2017-eular.6141
Annals of the Rheumatic Diseases, 76, 463-463. BMJ Publishing Group

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::fe208ace5b3c4e7cbe55a5fa40c7b7d9
https://research.vumc.nl/en/publications/bac6fafe-3868-44a4-9941-3a1ee3198780

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.

Autor: Schneider BJ; University of Michigan Health System, Ann Arbor, MI., Naidoo J; Beaumont Hospital, Dublin, Ireland.; Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD., Santomasso BD; Memorial Sloan Kettering Cancer Center, New York, NY., Lacchetti C; American Society of Clinical Oncology, Alexandria, VA., Adkins S; MD Anderson Cancer Center, Houston, TX., Anadkat M; Washington University, St Louis, MO., Atkins MB; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC., Brassil KJ; MD Anderson Cancer Center, Houston, TX., Caterino JM; The Ohio State University Wexner Medical Center, Columbus, OH., Chau I; Royal Marsden Hospital and Institute of Cancer Research, London & Surrey, Sutton, UK., Davies MJ; Smilow Cancer Hospital and Yale School of Nursing; New Haven, CT., Ernstoff MS; National Cancer Institute, Bethesda, MD., Fecher L; University of Michigan Health System, Ann Arbor, MI., Ghosh M; University of Michigan, Ann Arbor, MI., Jaiyesimi I; Cancer Care Associates PC, Royal Oak, MI., Mammen JS; Johns Hopkins University, Baltimore, MD., Naing A; MD Anderson Cancer Center, Houston, TX., Nastoupil LJ; MD Anderson Cancer Center, Houston, TX., Phillips T; City of Hope, Duarte, CA., Porter LD; Patient Advocate, Colon Cancer Alliance, Washington, DC., Reichner CA; Georgetown University, Washington, DC., Seigel C; Patient Advocate, MGH Cancer Center, Boston, MA., Song JM; Cleveland Clinic, Cleveland, OH., Spira A; Virginia Cancer Specialists and US Oncology, Fairfax, VA., Suarez-Almazor M; MD Anderson Cancer Center, Houston, TX., Swami U; Huntsman Cancer Institute-University of Utah, Salt Lake City, UT., Thompson JA; Seattle Cancer Care Alliance, University of Washington/Fred Hutchinson, Seattle, WA., Vikas P; University of Iowa, Iowa City, IA., Wang Y; MD Anderson Cancer Center, Houston, TX., Weber JS; NYU Langone Medical Center, New York, NY., Funchain P; Cleveland Clinic, Cleveland, OH., Bollin K; Scripps MD Anderson Cancer Center, San Diego, CA.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Dec 20; Vol. 39 (36), pp. 4073-4126. Date of Electronic Publication: 2021 Nov 01.